Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study. (Q51821379)

13 April 2018

title

Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study. (English)

1 reference

13 April 2018

main subject

osteoporosis

0 references

author

Gianluca Della Vedova

5

1 reference

13 April 2018

author name string

Arianna Ghirardi

1

1 reference

13 April 2018

Mauro Di Bari

2

1 reference

13 April 2018

Antonella Zambon

3

1 reference

13 April 2018

Lorenza Scotti

4

1 reference

13 April 2018

Francesco Lapi

6

1 reference

13 April 2018

Francesco Cipriani

7

1 reference

13 April 2018

Achille P Caputi

8

1 reference

13 April 2018

Alberto Vaccheri

9

1 reference

13 April 2018

Dario Gregori

10

1 reference

13 April 2018

Rosaria Gesuita

11

1 reference

13 April 2018

Annarita Vestri

12

1 reference

13 April 2018

Tommaso Staniscia

13

1 reference

13 April 2018

Giampiero Mazzaglia

14

1 reference

13 April 2018

Giovanni Corrao

15

1 reference

13 April 2018

BEST investigators

16

1 reference

13 April 2018

publication date

22 June 2014

1 reference

13 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

13 April 2018

volume

70

1 reference

13 April 2018

page(s)

1129-1137

1 reference

13 April 2018

issue

9

1 reference

13 April 2018

https://scigraph.springernature.com/pub.10.1007/s00228-014-1708-8

exact match

0 references

cites work

Osteoporosis: a still increasing prevalence

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Hip fractures in Italy: 2000-2005 extension study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

World-wide projections for hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Mortality and morbidity after hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Prognostic stratification of older persons based on simple administrative data: development and validation of the "Silver Code," to be used in emergency department triage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Low bone mineral density and risk of fracture in white female nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Axial and appendicular bone density predict fractures in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Cost-effectiveness of enhancing adherence with oral bisphosphonates treatment in osteoporotic women: an empirical approach based on healthcare utilisation databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Compliance with drug therapies for the treatment and prevention of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

The hospital burden of vertebral fracture in Europe: a study of national register sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Risk of Mortality Following Clinical Fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1708-8

Compliance with osteoporosis drug therapy and risk of fracture

21 January 2018

1 reference

12 December 2020

Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment

1 reference

12 December 2020

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

Adding "value" to clinical practice guidelines.

1 reference

12 December 2020

Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence

1 reference

12 December 2020

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

10.1007/S00228-014-1708-8

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

24951915

1 reference

13 April 2018